ELI LILLY AND COMPANY Property, Plant and Equipment, Gross
ELI LILLY AND COMPANY (LLY) had Property, Plant and Equipment, Gross of $28.89 billion as of 2024-12-31, per its 10-K filed 2025-02-19.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2025-02-19
- 2024-12-31: Property, Plant and Equipment, Gross $28.89B.
- 2023-12-31: Property, Plant and Equipment, Gross $24.01B.
- 2022-12-31: Property, Plant and Equipment, Gross $20.38B.
- 2021-12-31: Property, Plant and Equipment, Gross $18.96B.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2024-12-31 | $28.89B 10-K · filed 2025-02-19 | |
| 2023-12-31 | $24.01B 10-K · filed 2025-02-19 | |
| 2022-12-31 | $20.38B 10-K · filed 2024-02-21 | |
| 2021-12-31 | $18.96B 10-K · filed 2023-02-22 | |
| 2020-12-31 | $18.25B 10-K · filed 2022-02-23 | |
| 2019-12-31 | $17.03B 10-K · filed 2021-02-17 | |
| 2018-12-31 | $16.66B 10-K · filed 2020-02-19 | $18.46B 10-K · filed 2019-02-19 |
| 2017-12-31 | $16.28B 8-K · filed 2019-10-24 | $18.09B 10-K · filed 2018-02-20 |
| 2017-09-30 | $17.73B 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $17.53B 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $17.14B 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $16.78B 10-K · filed 2018-02-20 | |
| 2016-09-30 | $17.24B 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $16.93B 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $16.78B 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $16.66B 10-K · filed 2017-02-21 | |
| 2015-09-30 | $16.61B 10-Q · filed 2015-10-30 | |
| 2015-06-30 | $16.40B 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $16.21B 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $16.03B 10-K · filed 2016-02-19 | |
| 2014-09-30 | $16.08B 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $16.11B 10-Q · filed 2014-07-28 | |
| 2014-03-31 | $15.78B 10-Q · filed 2014-04-28 | |
| 2013-12-31 | $15.65B 10-K · filed 2015-02-19 | |
| 2013-09-30 | $15.34B 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $15.04B 10-Q · filed 2013-07-26 | |
| 2013-03-31 | $14.89B 10-Q · filed 2013-04-26 | |
| 2012-12-31 | $14.92B 10-K · filed 2014-02-19 | |
| 2012-09-30 | $14.94B 10-Q · filed 2012-10-26 | |
| 2012-06-30 | $14.71B 10-Q · filed 2012-07-27 | |
| 2012-03-31 | $14.77B 10-Q · filed 2012-04-30 | |
| 2011-12-31 | $14.59B 10-K · filed 2013-02-21 | |
| 2011-09-30 | $14.62B 10-Q · filed 2011-10-28 | |
| 2011-06-30 | $14.67B 10-Q · filed 2011-07-29 | |
| 2011-03-31 | $14.54B 10-Q · filed 2011-04-29 | |
| 2010-12-31 | $14.49B 10-K · filed 2012-02-24 | |
| 2010-09-30 | $14.42B 10-Q · filed 2010-10-29 | |
| 2010-06-30 | $14.04B 10-Q/A · filed 2010-08-02 | |
| 2010-03-31 | $14.18B 10-Q · filed 2010-07-30 | |
| 2009-12-31 | $15.10B 10-K · filed 2011-02-22 | |
| 2009-09-30 | $15.19B 10-Q · filed 2009-10-30 | |
| 2009-06-30 | $15.22B 10-Q · filed 2009-07-31 | |
| 2008-12-31 | $15.32B 10-Q · filed 2009-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |